Tumor-initiating label-retaining cancer cells in human gastrointestinal cancers undergo asymmetric cell division
about
The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cellsDecreased H3K27 and H3K4 trimethylation on mortal chromosomes in distributed stem cells.Wnt and the cancer niche: paracrine interactions with gastrointestinal cancer cells undergoing asymmetric cell divisionSparse feature selection identifies H2A.Z as a novel, pattern-specific biomarker for asymmetrically self-renewing distributed stem cells.Differential Sensitivities of Fast- and Slow-cycling Cancer Cells to Inosine Monophosphate Dehydrogenase 2 Inhibition by Mycophenolic Acid.Asymmetric chromatid segregation in cardiac progenitor cells is enhanced by Pim-1 kinase.A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers.Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype.Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell PopulationColorectal cancer biomarkers and the potential role of cancer stem cells.Liver Label Retaining Cancer Cells Are Relatively Resistant to the Reported Anti-Cancer Stem Cell Drug Metformin.Strategies for isolating and enriching cancer stem cells: well begun is half doneHigher 5-hydroxymethylcytosine identifies immortal DNA strand chromosomes in asymmetrically self-renewing distributed stem cells.New cancer diagnostics and therapeutics from a ninth 'hallmark of cancer': symmetric self-renewal by mutated distributed stem cells.Telomerase as a "stemness" enzyme.Concise reviews: cancer stem cells: from concept to cure.Label-retaining liver cancer cells are relatively resistant to sorafenib.Colorectal cancer stem cells as biomarkers: where it all starts?Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.
P2860
Q21559479-2BCBE352-F598-4849-9995-02FA8A4F77A7Q27330517-07A998EA-4BBF-40EF-9AE6-DCDBA17E40A9Q28295679-53F00424-E450-412F-81E5-74E5BD3FBF59Q35186689-2EE359D6-3B30-47BE-80B8-BF6F1A8E6A2EQ35807620-9993363D-5F4F-4352-A788-91A689C53856Q35976872-07BCE608-C03E-47D0-894E-B1347551D9F3Q36005675-D851006D-35A6-44EE-B89B-5EFA79EB0014Q36413760-1016066A-5554-41FF-A6A0-3817257539A7Q36471425-11BD879C-A8E0-4DC6-8097-56955A0B30FBQ36646553-E670BAF8-D74D-4C9B-8528-63AE1AD24B0BQ37015746-5C070281-63E9-461D-B535-FF9C6610F981Q37061915-F6971702-9C17-4F23-9F5B-BF6EB4EBCB1FQ37240619-79D815E7-6703-4E34-9FCD-15474603F5FFQ38154929-CB14416B-F01F-4732-B47F-76795E10FF15Q38211826-C1ED0234-DF43-498E-B079-026414F27682Q38235552-213BECA0-B60B-41BD-9308-CABCE69FEDDAQ39194290-3DEE38CC-F268-47CC-ACF1-C3A4DBC6E299Q45888881-B6589ECC-BB9F-4086-8142-22F952000A6CQ46051896-F8DF019B-0931-4E21-9B48-0E7236964076
P2860
Tumor-initiating label-retaining cancer cells in human gastrointestinal cancers undergo asymmetric cell division
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Tumor-initiating label-retaini ...... dergo asymmetric cell division
@ast
Tumor-initiating label-retaini ...... dergo asymmetric cell division
@en
type
label
Tumor-initiating label-retaini ...... dergo asymmetric cell division
@ast
Tumor-initiating label-retaini ...... dergo asymmetric cell division
@en
prefLabel
Tumor-initiating label-retaini ...... dergo asymmetric cell division
@ast
Tumor-initiating label-retaini ...... dergo asymmetric cell division
@en
P2093
P2860
P356
P1433
P1476
Tumor-initiating label-retaini ...... dergo asymmetric cell division
@en
P2093
Andrew J Anderson
Chenwi M Ambe
Danielle M Hari
Gordon W Wiegand
Hong-Wu Xin
Itzhak Avital
John E Mullinax
Satyajit Ray
Snorri S Thorgeirsson
Susan H Garfield
P2860
P304
P356
10.1002/STEM.1061
P577
2012-04-01T00:00:00Z